156 related articles for article (PubMed ID: 37671594)
1. Tumor size and survival in intrahepatic cholangiocarcinoma treated with surgical resection or ablation.
Kanu EN; Rhodin KE; Masoud SJ; Eckhoff AM; Bartholomew AJ; Howell TC; Bao J; Befera NT; Kim CY; Blazer DG; Zani S; Nussbaum DP; Allen PJ; Lidsky ME
J Surg Oncol; 2023 Dec; 128(8):1329-1339. PubMed ID: 37671594
[TBL] [Abstract][Full Text] [Related]
2. Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic Cholangiocarcinoma.
Masoud SJ; Rhodin KE; Kanu E; Bao J; Eckhoff AM; Bartholomew AJ; Howell TC; Aykut B; Kosovec JE; Palta M; Befera NT; Kim CY; Herbert G; Shah KN; Nussbaum DP; Blazer DG; Zani S; Allen PJ; Lidsky ME
Ann Surg Oncol; 2023 Oct; 30(11):6639-6646. PubMed ID: 37436606
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma.
Sposito C; Ratti F; Cucchetti A; Ardito F; Ruzzenente A; Di Sandro S; Maspero M; Ercolani G; Di Benedetto F; Guglielmi A; Giuliante F; Aldrighetti L; Mazzaferro V
J Hepatol; 2023 Feb; 78(2):356-363. PubMed ID: 36328332
[TBL] [Abstract][Full Text] [Related]
4. Contemporary trends and outcomes after liver transplantation and resection for intrahepatic cholangiocarcinoma.
Howell TC; Rhodin KE; Shaw B; Bao J; Kanu E; Masoud S; Bartholomew AJ; Gao Q; Anwar IJ; Ladowski JM; Nussbaum DP; Blazer DG; Zani S; Allen PJ; Barbas AS; Lidsky ME
J Gastrointest Surg; 2024 May; 28(5):738-745. PubMed ID: 38704208
[TBL] [Abstract][Full Text] [Related]
5. Role of surgical treatment for hepatolithiasis-associated intrahepatic cholangiocarcinoma: A retrospective study in a single institution.
Xiao J; Zhu J; Liu Z; Wan R; Li Y; Xiao W
J Cancer Res Ther; 2017; 13(5):756-760. PubMed ID: 29237899
[TBL] [Abstract][Full Text] [Related]
6. Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database.
Salehi O; Kazakova V; Vega EA; Kutlu OC; Alarcon SV; Freeman R; Kozyreva O; Conrad C
Surg Endosc; 2022 Jul; 36(7):5382-5391. PubMed ID: 34750709
[TBL] [Abstract][Full Text] [Related]
7. Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States.
Lee YT; Singal AG; Lauzon M; Agopian VG; Luu M; Noureddin M; Todo T; Kim IK; Friedman ML; Kosari K; Nissen NN; Roberts LR; Heimbach JK; Gores GJ; Yang JD
Cancer; 2022 Oct; 128(20):3610-3619. PubMed ID: 35997126
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of surgical treatment of intrahepatic cholangiocarcinoma.
Gurmikov BN; Vishnevsky VA; Kovalenko YA; Chzhao AV
Khirurgiia (Mosk); 2020; (5):5-11. PubMed ID: 32500683
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma.
Franssen S; Soares KC; Jolissaint JS; Tsilimigras DI; Buettner S; Alexandrescu S; Marques H; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Margonis GA; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Marsh JW; Cercek A; Kemeny N; Kingham TP; D'Angelica M; Pawlik TM; Jarnagin WR; Koerkamp BG
JAMA Surg; 2022 Jul; 157(7):590-596. PubMed ID: 35544131
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
12. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
14. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.
Clark CJ; Wood-Wentz CM; Reid-Lombardo KM; Kendrick ML; Huebner M; Que FG
HPB (Oxford); 2011 Sep; 13(9):612-20. PubMed ID: 21843261
[TBL] [Abstract][Full Text] [Related]
15. Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience.
Ali SM; Clark CJ; Mounajjed T; Wu TT; Harmsen WS; Reid-Lombardo KM; Truty MJ; Kendrick ML; Farnell MB; Nagorney DM; Que FG
HPB (Oxford); 2015 Mar; 17(3):244-50. PubMed ID: 25410716
[TBL] [Abstract][Full Text] [Related]
16. A National Assessment of T2 Staging for Intrahepatic Cholangiocarcinoma and the Poor Prognosis Associated with Multifocality.
Turner KM; Delman AM; Kharofa J; Olowokure O; Sohal D; Quillin RC; Shah SA; Ahmad SA; Patel SH; Wilson GC
Ann Surg Oncol; 2022 Aug; 29(8):5094-5102. PubMed ID: 35441906
[TBL] [Abstract][Full Text] [Related]
17. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
18. Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma.
Yu Q; Ungchusri E; Pillai A; Liao CY; Baker T; Fung J; DiSabato D; Zhang M; Liao C; Van Ha T; Ahmed O
Eur Radiol; 2024 Apr; 34(4):2374-2383. PubMed ID: 37812295
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes.
Chu HH; Kim JH; Shin YM; Won HJ; Kim PN
AJR Am J Roentgenol; 2021 Aug; 217(2):426-432. PubMed ID: 34076458
[No Abstract] [Full Text] [Related]
20. Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.
Bagante F; Spolverato G; Merath K; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Endo I; Pawlik TM
Surgery; 2019 Dec; 166(6):983-990. PubMed ID: 31326191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]